Method for Reducing Scarring During Wound Healing Using Antisense Compounds Directed to CTGF

This invention provides a method for reducing hypertropic scarring resulting from dermal wound healing in a subject in need which comprises administering to the subject an antisense oligonucleotide which inhibits expression of connective tissue growth factor (CTGF) in an amount effective to inhibit expression of CTGF and thereby reduce hypertrophic scarring.

Patents:
EP 2,334,319   [MORE INFO]

Inventor(s): DEAN NICOLAS M [US]; MUSTOE THOMAS A [US]; SISCO MARK [US]; KRYGER ZOL [US]; BENNET FRANK C [US]

Type of Offer: Licensing



Next Patent »
« More Medical Patents

Share on      


CrowdSell Your Patent